G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.
Malaria elimination will be possible only with serious attempts to address asymptomatic infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently available drugs that can completely clear a human of P. vivax (known as "radical cure"), and that can reduce...
| मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| स्वरूप: | Journal article |
| भाषा: | English |
| प्रकाशित: |
2013
|
| _version_ | 1826292386433597440 |
|---|---|
| author | Domingo, G Satyagraha, A Anvikar, A Baird, K Bancone, G Bansil, P Carter, N Cheng, Q Culpepper, J Eziefula, C Fukuda, M Green, J Hwang, J Lacerda, M McGray, S Menard, D Nosten, F Nuchprayoon, I Oo, N Bualombai, P Pumpradit, W Qian, K Recht, J Roca, A Satimai, W |
| author_facet | Domingo, G Satyagraha, A Anvikar, A Baird, K Bancone, G Bansil, P Carter, N Cheng, Q Culpepper, J Eziefula, C Fukuda, M Green, J Hwang, J Lacerda, M McGray, S Menard, D Nosten, F Nuchprayoon, I Oo, N Bualombai, P Pumpradit, W Qian, K Recht, J Roca, A Satimai, W |
| author_sort | Domingo, G |
| collection | OXFORD |
| description | Malaria elimination will be possible only with serious attempts to address asymptomatic infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently available drugs that can completely clear a human of P. vivax (known as "radical cure"), and that can reduce transmission of malaria parasites, are those in the 8-aminoquinoline drug family, such as primaquine. Unfortunately, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency risk having severe adverse reactions if exposed to these drugs at certain doses. G6PD deficiency is the most common human enzyme defect, affecting approximately 400 million people worldwide.Scaling up radical cure regimens will require testing for G6PD deficiency, at two levels: 1) the individual level to ensure safe case management, and 2) the population level to understand the risk in the local population to guide Plasmodium vivax treatment policy. Several technical and operational knowledge gaps must be addressed to expand access to G6PD deficiency testing and to ensure that a patient's G6PD status is known before deciding to administer an 8-aminoquinoline-based drug.In this report from a stakeholder meeting held in Thailand on October 4 and 5, 2012, G6PD testing in support of radical cure is discussed in detail. The focus is on challenges to the development and evaluation of G6PD diagnostic tests, and on challenges related to the operational aspects of implementing G6PD testing in support of radical cure. The report also describes recommendations for evaluation of diagnostic tests for G6PD deficiency in support of radical cure. |
| first_indexed | 2024-03-07T03:13:53Z |
| format | Journal article |
| id | oxford-uuid:b52186e6-01b1-4ea5-8b13-81b1ebf603b4 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:13:53Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:b52186e6-01b1-4ea5-8b13-81b1ebf603b42022-03-27T04:31:12ZG6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b52186e6-01b1-4ea5-8b13-81b1ebf603b4EnglishSymplectic Elements at Oxford2013Domingo, GSatyagraha, AAnvikar, ABaird, KBancone, GBansil, PCarter, NCheng, QCulpepper, JEziefula, CFukuda, MGreen, JHwang, JLacerda, MMcGray, SMenard, DNosten, FNuchprayoon, IOo, NBualombai, PPumpradit, WQian, KRecht, JRoca, ASatimai, WMalaria elimination will be possible only with serious attempts to address asymptomatic infection and chronic infection by both Plasmodium falciparum and Plasmodium vivax. Currently available drugs that can completely clear a human of P. vivax (known as "radical cure"), and that can reduce transmission of malaria parasites, are those in the 8-aminoquinoline drug family, such as primaquine. Unfortunately, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency risk having severe adverse reactions if exposed to these drugs at certain doses. G6PD deficiency is the most common human enzyme defect, affecting approximately 400 million people worldwide.Scaling up radical cure regimens will require testing for G6PD deficiency, at two levels: 1) the individual level to ensure safe case management, and 2) the population level to understand the risk in the local population to guide Plasmodium vivax treatment policy. Several technical and operational knowledge gaps must be addressed to expand access to G6PD deficiency testing and to ensure that a patient's G6PD status is known before deciding to administer an 8-aminoquinoline-based drug.In this report from a stakeholder meeting held in Thailand on October 4 and 5, 2012, G6PD testing in support of radical cure is discussed in detail. The focus is on challenges to the development and evaluation of G6PD diagnostic tests, and on challenges related to the operational aspects of implementing G6PD testing in support of radical cure. The report also describes recommendations for evaluation of diagnostic tests for G6PD deficiency in support of radical cure. |
| spellingShingle | Domingo, G Satyagraha, A Anvikar, A Baird, K Bancone, G Bansil, P Carter, N Cheng, Q Culpepper, J Eziefula, C Fukuda, M Green, J Hwang, J Lacerda, M McGray, S Menard, D Nosten, F Nuchprayoon, I Oo, N Bualombai, P Pumpradit, W Qian, K Recht, J Roca, A Satimai, W G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title | G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title_full | G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title_fullStr | G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title_full_unstemmed | G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title_short | G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. |
| title_sort | g6pd testing in support of treatment and elimination of malaria recommendations for evaluation of g6pd tests |
| work_keys_str_mv | AT domingog g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT satyagrahaa g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT anvikara g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT bairdk g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT banconeg g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT bansilp g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT cartern g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT chengq g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT culpepperj g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT eziefulac g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT fukudam g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT greenj g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT hwangj g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT lacerdam g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT mcgrays g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT menardd g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT nostenf g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT nuchprayooni g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT oon g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT bualombaip g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT pumpraditw g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT qiank g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT rechtj g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT rocaa g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests AT satimaiw g6pdtestinginsupportoftreatmentandeliminationofmalariarecommendationsforevaluationofg6pdtests |